Legacy Education (LGCY) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
14 May, 2026Executive summary
Achieved record-breaking Q3 2026 with revenue up 15% year-over-year to $21.4 million, driven by higher student enrollment and new program launches.
Net income for Q3 2026 rose 7.5% to $3.0 million, with diluted EPS up to $0.22 and adjusted EBITDA up 12.6% to $4.4 million.
Expanded program offerings and improved retention led to organic growth from a larger, mature platform.
Investments in facilities and capacity, including expansions at Lancaster and Temecula, support future enrollment and program expansion.
Maintained compliance, received reaccreditations, and continued to monitor regulatory developments.
Financial highlights
Q3 2026 revenue: $21.4 million (+15% YoY); nine-month revenue: $60.0 million (+29.7% YoY).
Q3 2026 net income: $3.0 million (+7.5% YoY); nine-month net income: $7.3 million (+15.1% YoY).
Adjusted EBITDA for Q3 2026: $4.4 million (+12.6% YoY); nine-month adjusted EBITDA: $10.5 million (+22.3% YoY).
Diluted EPS for Q3 2026: $0.22 (+4.8% YoY); nine-month diluted EPS: $0.52.
Cash and equivalents at $21.7 million as of March 31, 2026; working capital $30.9 million; debt minimal at $600K.
Outlook and guidance
Focused on organic growth via new programs, branch expansion, and selective acquisitions.
Enrollment ramp at expanded campuses expected to increase student capacity by 200-400 per campus over 1-2 years.
New branch outside California planned, with capacity for 600-800 students over several years.
Continued ramp-up of new programs, including MRI and cardiac sonography in Q4.
Evaluating impact of new federal regulations on student loan limits and program eligibility.
Latest events from Legacy Education
- Achieved 42% revenue growth and 17% enrollment growth, with strong student outcomes and robust liquidity.LGCY
Investor presentation20 Mar 2026 - Q2 revenue up 40.7% and net income up 46%, fueled by enrollment and program expansion.LGCY
Q2 202620 Mar 2026 - Achieved 40% revenue growth and 38% enrollment increase, driven by healthcare-focused programs and acquisitions.LGCY
Investor presentation12 Feb 2026 - Revenue up 35%, net income doubled, and expansion fueled by IPO and $8M acquisition.LGCY
Q1 202514 Jan 2026 - Q2 FY2025 revenue up 29.2% with record enrollment and expanded healthcare offerings.LGCY
Q2 202516 Dec 2025 - Virtual meeting to elect six directors, ratify auditor, and review governance and compensation.LGCY
Proxy Filing2 Dec 2025 - Annual proxy details voting items and confirms standard shareholder rights.LGCY
Proxy Filing2 Dec 2025 - IPO targets $10.28M for expansion, with strong growth but high regulatory risk.LGCY
Registration Filing29 Nov 2025 - IPO seeks $10.28M to fund growth, with strong financials but high regulatory exposure.LGCY
Registration Filing29 Nov 2025